Pharma stocks upbeat amid Covid-19 scare; Divi's, Lupin can gain up to 10%

Technically, the Nifty Pharma index needs to immediate hurdle at 13,500, for further upside to 14,250.

Avdhut Bagkar |Business Standard | Mumbai
PremiumWeb Exclusive
Pharma stocks upbeat amid Covid-19 scare; Divi's, Lupin can gain up to 10%

4 min read Last Updated : Dec 23 2022 | 12:19 PM IST

Listen to This Article

Stock markets across the globe this traded on a jittery note amid reports of fresh spike in COVID-19 cases across China, and also cities in the US, Europe and Japan. The Indian markets slipped over 2

Topics :CoronavirusDivis LaboratoriesNifty PharmaLupinMarket technicalsMarket trendsPharma stocksstocks technical analysistechnical chartsTrading strategiesStocks to buy

First Published: Dec 23 2022 | 11:38 AM IST

Next Story